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Abstract
The development of effective diagnostic tools will be essential in the continuing fight to
reduce schistosome infection; however, the diagnostic tests available to date are generally
laborious and difficult to implement in current parasite control strategies. We generated a
series of single-chain antibody Fv domain (scFv) phage display libraries from the portal
lymph node of field exposed water buffaloes,Bubalus bubalis, 11–12 days post challenge
with Schistosoma japonicum cercariae. The selected scFv-phages showed clear enrichment
towards adult schistosomes and excretory-secretory (ES) proteins by immunofluorescence,
ELISA and western blot analysis. The enriched libraries were used to probe a schistosome
specific protein microarray resulting in the recognition of a number of proteins, five of which
were specific to schistosomes, with RNA expression predominantly in the adult life-stage
based on interrogation of schistosome expressed sequence tags (EST). As the libraries
were enriched by panning against ES products, these antigens may be excreted or secreted
into the host vasculature and hence may make good targets for a diagnostic assay. Further
selection of the scFv library against infected mouse sera identified five soluble scFv clones
that could selectively recognise soluble whole adult preparations (SWAP) relative to an irrel-
evant protein control (ovalbumin). Furthermore, two of the identified scFv clones also selec-
tively recognised SWAP proteins when spiked into naïve mouse sera. These host B-cell
derived scFvs that specifically bind to schistosome protein preparations will be valuable
reagents for further development of a cost effective point-of-care diagnostic test.
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Author Summary
Mass drug administration using the highly effective drug praziquantel (PZQ) is currently
the method of choice to combat schistosomiasis. However, this treatment regime has limi-
tations; in particular, it does not prevent re-infection and sporadic parasite resistance
against PZQ is a continuing threat. The path to the successful control of schistosomiasis is
highly challenging and must consider, not only the complex nature of the host-parasite
interaction, but also the capacity to assess disease burden and parasite re-emergence in
communities where successful control has been achieved. Furthermore, control programs
must be economically sustainable in endemic countries and despite significant recent
advancements the elimination of schistosomiasis may still be some time away. Accord-
ingly, there is a definitive need to formulate innovative approaches for the development of
improved diagnostic tools to accurately assess the disease burden associated with active
schistosome infections. Here we describe the usefulness of a phage display library to
mature antibody fragments derived from lymph node RNA of the natural buffalo host of
the Asian schistosome, Schistosoma japonicum, following an experimental infection.
These mature antibody fragments were able to bind native parasite proteins and could
thus be used to develop a low cost and accurate point-of-care diagnostic test.
Introduction
Schistosomiasis is one of the most insidious of all the tropical parasitic infections and threatens
the health of hundreds of millions of people worldwide [1]. The last 20 years has seen remark-
able progress in disease control through the use of praziquantel (PZQ), but this drug does not
protect against re-infection and mass drug administration programmes based around its use
are probably untenable long term [2–4]. Recently there has been a major focus on the develop-
ment of anti-schistosome vaccines, but to date a protective commercial vaccine remains elusive
[1]. As mass drug administration decreases worm burdens within endemic areas, the need for
improved diagnostic tests should be given research priority [5]. However, in countries where
elimination of schistosomiasis has been given precedence, case detection of infected individuals
remains problematic as the commonly used methods for diagnosis lack the necessary sensitiv-
ity and specificity to accurately determine parasite burden [6]. Although application of modern
research laboratory techniques has seen improvements in the diagnosis of helminth infection,
uptake has not been uniform and proof of concept studies that show promise have often not
been followed through with much needed product development [7].
Currently the Kato-Katz thick smear stool method, based on detection of eggs in faeces, is
the test sanctioned by the World Health Organization (WHO) for qualitative and quantitative
diagnosis of intestinal schistosomiasis [8, 9]. This test is generally specific, simple and relatively
inexpensive, but like many parasitological tests, sensitivity can be insufficient, particularly
when worm burdens are low [7]. Consequently, the use of single Kato-Katz measurements can
underestimate the prevalence of infection and can confound confirmation of cure assessment
following chemotherapy [10]. This is of particular importance in the Peoples Republic (PR) of
China as the country moves towards programs aimed at the elimination of schistosomiasis
japonica [11, 12]. Since the 1950’s the prevalence of schistosomiasis japonica within Chinese
provinces has dramatically decreased [13, 14] and the requirements for a diagnostic tool has
moved from the detection of parasitic infection to the ability to effectively assess disease preva-
lence [14].
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Evaluation of the Gates-funded SCORE project in African countries demonstrated that a
rapid, accurate point-of-care (POC) diagnostic test that detects a circulating cathodic antigen
(CCA) could identify S.mansoni antigens [15, 16]. The CCA and circulating anodic antigen
(CAA) have been investigated as potential diagnostic candidates and can be detected in the
serum and urine of infected individuals [17, 18]. These antigens are cleared from the serum
and urine of schistosomiasis patients within weeks following curative treatment [19]. However,
success of these tests has only been validated for areas of high and moderate endemicity [18,
20]. Whilst CCA and CAA appear to be excellent antigen based tests, we have taken a different
approach that may offer advantages for the development of reagents aimed at detecting very
low infection levels.
Recently McWilliam et al., demonstrated, in a rat model of schistosomiasis, that the devel-
oping schistosome worm can elicit a distinct immune response in discrete tissue sites [21].
Building on this concept we previously published the construction of an scFv-phage library for
the detection of larval stage antigens as potential vaccine candidates [22]. However, the S. japo-
nicum larval stages are small, transient and rapidly migrate between tissues. The adult parasites
are much larger, more persistent and shed antigen directly into the blood which makes them
much more attractive targets for an antigen based diagnostic. Here we describe the construc-
tion and characterisation of scFv libraries derived from the portal lymph nodes of S. japonicum
infected B. bubalis, and demonstrate their ability to bind to the surface of adult S. japonicum
worms and excretory-secretory (ES) products. These reagents offer many advantages for diag-
nostic development, including the ability to affinity mature the reagents, easy selection in a
number of modalities, existing detection reagents and strong binding. It is hoped these reagents
can be developed into a rapid POC diagnostic to aid in the surveillance and eventual elimina-
tion of S. japonicum.
Materials and Methods
Ethics statement
Written approval for animal experiments was provided by the Ethical Review Board of the
Hunan Institute of Parasitic Diseases (approval # 110818) and fromMonash University Ani-
mal Ethics Committee (approval # 2011-124-FW). Animals were maintained and cared for
according to the Animal Ethics and Procedures Guidelines of the PR China.
Parasite collection and crude protein extracts
Cercariae from S. japonicum were shed from infected Oncomelania hupensis snails collected
from an endemic region in the People’s Republic (PR) of China using described methods [23,
24]. Adult S. japonicum worm pairs were collected from infected mice at QIMR Berghofer
Institute for Medical Research as described [25]. Extracts of soluble whole adult preparations
(SWAP) or excretory-secretory (ES) products from live adult worms were prepared as
described [26, 27]. Soluble egg antigen (SEA) was generated from eggs extracted from infected
livers digested in 400 μg/ml collagenase B overnight at 37°C. The digested liver solution was
centrifuged (400 g, 5 min) and washed extensively in PBS. The washed solution was then
passed though sieves (250μm and 150μm, respectively) and eggs were separated out of the
resulting solution using a Percoll gradient and exposed to 10 freeze thaw cycles. Eggs were then
homogenised and centrifuged at 10,000 g for 2 hr at 4°C and the soluble fraction (SEA) col-
lected. Protein concentrations were determined by bicinchoninic acid assay (BCA; Thermo
Fisher Scientific, USA).
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Experimental animal infections and sample collection
Animal experiments and sample collection were conducted in the PR China as described [28].
Briefly, six mixed sex S. japonicum infected B. bubalis were obtained from an S. japonicum-
endemic region in Hunan Province, PR China. Pre-existing infection status was confirmed by
faecal egg count to provide animals where natural immunity could be “boosted” by subsequent
experimental schistosome infection. All animals were drenched upon arrival with PZQ (25 mg/
kg) and randomly assigned into two experimental groups (n = 3 per group). Group 1 was
infected with 400 live S. japonicum cercariae percutaneously on the inner thigh. Group 2 was
the uninfected control group. Animals were sacrificed 11–12 days post infection (days p.i.).
Collection of liver-draining lymph node samples
Lymph nodes draining the liver of B. bubalis were collected and cells isolated as described pre-
viously [29]. For RNA preparation, 1 x 109 cells were centrifuged and the cell pellet resus-
pended in 2 ml of QIAzol lysis buffer (QIAGEN, Netherlands) and RNA was prepared
according to the manufacturer’s recommendations. RNA was further purified using an RNeasy
Mini Kit (QIAGEN, Netherlands) as per the manufacturer’s recommendations. RNA was
quantitated via absorbance at 260 nm using a NanoDrop spectrophotometer (Thermo Fisher
Scientific, USA) and stored at -80°C until required.
Construction and amplification of B-cell scFv-phage antibody libraries
The preparation and characterisation of a scFv-phage display library similar to that used in this
study has been described previously [22]. Briefly, full length variable light (VL) and variable
heavy (VH) chain genes were amplified by PCR from portal-lymph node RNA derived from
buffalo 11–12 days following an experimental S. japonicum infection. The scFv fragment was
cloned into a phage display vector (pAK100; Plückthan Laboratory, University of Zurich, Swit-
zerland) with the VL and VH genes separated by DNA encoding a flexible linker sequence
(VL-(G4S)4-VH). The scFv fragment was directionally cloned into the pAK100 vector using
differential SfiI restriction sites and was fused in-frame to the phage gene III coding DNA. This
library was transformed in XL-1 Blue Escherichia coli cells and approximately 5 x 107 transfor-
mants were recovered following overnight incubation at 37°C. The panning library was ampli-
fied by inoculating 50 ml of non-expressing (NE) medium (2 X Yeast Tryptone (2YT), 1%
glucose, 25 mg/ml chloramphenicol) with approximately 109 XL-1 Blue E. coli cells containing
scFv phagemids and shaken at 37°C. At OD600 = 0.5, 1 x 10
11 transducing units per ml (TU/
ml) M13K07 helper-phage (New England Biolabs, USA) and 25 μl 1 M Isopropyl β-D-1-thio-
galactopyranoside (IPTG; Sigma-Aldrich, USA) solution were added and culture incubated for
15 mins at 37°C without agitation. The culture was then centrifuged at 3500 g for 10 mins and
the resulting pellet was diluted in 100 ml low-expression (LE) medium (2YT, 1% glucose, 25
mg/ml chloramphenicol (Sigma Aldrich, USA) and 0.5 mM IPTG) and shaken for 16 hr at
37°C for phage production. Two hours post infection, 30 mg/ml kanamycin (Bioline, Australia)
was added. Resulting scFv-phage particles were purified and concentrated 100-fold by PEG
NaCl precipitation [30], resuspended in phosphate buffered saline (PBS), and stored at 4°C.
Following overnight culture, phage titres of 1 x 1011–1 x1012 TU/ml were typically observed.
Plasmid DNA was sequenced by the Micromon Sequencing Facility (Monash University, Aus-
tralia) and aligned to Bos taurus antibody protein sequences using Clustal Omega Multiple
Sequence Alignment Software [31].
Diagnostic Development for Schistosoma japonicum
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004280 December 18, 2015 4 / 20
Selection of scFv-phage binders to adult worms or excretory-secretory
products
For selection of high affinity binders, 1 x 1011 scFv-phage particles in 1ml PBS were initially
pre-absorbed in 1.7 ml microfuge tubes (Axygen, Corning Life Sciences, USA) or 96 well
microplates (Corning Life Sciences, USA) for 1 hr at RT with agitation. This was repeated a
total of four times to eliminate scFv-phages that preferentially bind plastic. Following pre-
absorption, 1 x 1011 TU/ml scFv-phages were added to 10 ± 2 formaldehyde-fixed adult schis-
tosome pairs (10% formaldehyde for 30 mins followed by 3 washes with PBS) or 1 μg of ES
worm products (0.1 μg coated per well on a on 96 well plate) and allowed to bind for 2 hr at RT
with gentle agitation. Control reactions of scFv-phages without the addition of parasite mate-
rial were also prepared. Tubes and microplates were then washed 10 times with PBS with
0.05% (v/v) Tween-20 (PBS-T), followed by an additional two washes with PBS. Bound scFv-
phages were eluted with 0.2 M glycine/HCl, pH 3.0 for 15 min at RT. Supernatant from tubes
and microplates was then collected and immediately neutralised with appropriate volume of 1
M Tris-HCL. Eluted scFv-phages (typically 1 x 104–1 x106 TU/ml) were amplified as previously
outlined and resuspended in PBS. Amplified scFv-phages were used for further panning rounds
or parasite binding analysis. Libraries panned against adults or ES are termed Bp-R3-A or Bp-
R3-ES respectively and an equal mix of each scFv-pool is termed Bp-R3-AES. Combined
BP-R3-AES phage pools were used to minimise amount of S. japonicummaterial required.
Selection against infected mouse sera
Naïve and S. japonicum infected mouse sera (21 days p.i.; kindly supplied by Dr. Patrick Dri-
guez, QIMR Berghofer Medical Research Institute, Australia) were treated with Affi-Gel Blue
to remove albumin as per the manufacturer’s instructions (Bio-Rad, USA). The Bp-R3-AES
phage pool was adjusted to 1 x 1011 TU/ml and absorbed against depleted naïve mouse sera
(diluted 1:10 in PBS) coated onto 96 well microtitre plates (100 μl/well; Maxisorb; NUNC,
Denmark). Pre-absorbed Bp-R3-AES were then panned against depleted infected mouse sera
(diluted 1:10 in PBS) coated onto 96 well microtitre plates (100 μl/well; Maxisorb; NUNC,
Denmark). Following each panning round phages were eluted and amplified as previously out-
lined and again absorbed against depleted naïve mouse sera, before being further panned
against depleted infected mouse sera. This process was repeated for a total of three rounds.
This post infected mouse sera panned library will be termed Bp-R3-post infected mouse sera
(Bp-R3-PIMS).
Generation of soluble scFv clones
Selected scFv coding regions from Bp-R3 phages following infected mouse sera panning (Bp-
R3-PIMS) were sub-cloned into the E. coli expression vector pAK600 (Plückthun Laboratory,
University of Zurich, Switzerland) and transformed using electroporation into TOP 10 F’ E.
coli cells (Life Technologies, USA) as previously described [32]. The recombinant scFv are
expressed with an alkaline phosphatase (AP) tag to aid in solubility and to facilitate dimerisa-
tion and direct detection [33]. The scFv-AP fusions were purified by ion exchange chromatog-
raphy (HiTrap Q FF, GE Healthcare, UK) according to the manufacturer’s recommendations.
Purity and correct size of scFv-AP fusion proteins were assessed by western blot. Soluble scFv
clones were sequenced by the Micromon Sequencing Facility (Monash University, Australia)
and aligned using Clustal Omega Multiple Sequence Alignment Software [31]. Soluble scFv
fusion proteins were designated Bp-scFv-1 to Bp-scFv-5, respectively.
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Binding of Bp-R3 scFv-phages and soluble scFvs clones to schistosome
extracts by ELISA
Microplates (Corning Life Sciences, USA) were coated with 100 μl of either S. japonicum
SWAP, ES, SEA, ovalbumin (0.5 μg/well) or SWAP spiked into uninfected mouse sera (equiva-
lent to 0.5 μg/well in 1:10 diluted naïve mouse sera) in carbonate coating buffer (0.05 M car-
bonate-bicarbonate, pH 9.6) and incubated overnight at 4°C. The next day microplates were
washed three times and blocked in PBS-T for 1 hr at 37°C. The scFv-phage pools (Bp-pre, Bp-
R3-A, Bp-R3-ES, Bp-R3-AES or Bp-R3-PIMS) diluted 1:5 in PBS-T and soluble scFv-AP clones
diluted 1:10 in PBS-T were added to triplicate wells and incubated for 1 hr at 37°C. Specific
binding of scFv-phage pools was detected using an anti-M13 pIII monoclonal antibody (New
England Biolabs, USA) followed by biotin-conjugated anti-mouse antibody (goat anti-mouse
IgG Fc, Jackson Immunoresearch), then streptavidin-HRP (BioRad, USA). Reactivity of scFv-
AP clones towards schistosome antigens was detected using rabbit anti-alkaline phosphatase
(ABCAM, USA), then swine anti-rabbit-HRP conjugate (Dako, Germany) All detection anti-
bodies were diluted 1:1000 in PBS-T and incubated for 1 hr at 37°C. Following incubation, all
plates were washed three times with PBS-T and developed with 3,3’,5,5’-tetramethylbenzidine
(TMB) solution (Life Technologies, USA) for 15 minutes and the reaction was stopped with 2
M H2SO4. Antibody or scFv-phage binding was detected using O.D. measurements at 450 nm.
Western blotting
Protein preparations (SWAP or SEA) were resolved by reducing SDS-PAGE and transferred to
nitrocellulose membranes as per the manufactures recommendations (iBlot Dry Blotting Sys-
tem; Life Technologies, USA). Membranes were visualised with Ponceau S (0.1% (w/v) Pon-
ceau S in 5% acetic acid; Sigma-Aldrich, USA), cut into individual lanes and blocked for 2 hr at
RT in PBS-T. Membranes were incubated overnight at 4°C with Bp-R3-AES phages (diluted
1:5 in PBS-T). Individual lanes were washed three times with PBS-T and Bp-R3-AES phages
were detected with anti-M13 pIII monoclonal antibody (New England Biolabs, USA), followed
by biotin-conjugated anti-mouse antibody (goat anti-mouse IgG Fc, Jackson Immunoresearch,
USA), then streptavidin-HRP (BioRad, USA). All detection antibodies were diluted 1:1000 in
PBS-T and incubated for 1 hr at RT. Protein bands were detected using the metal enhanced
DAB peroxidase substrate detection system (Thermo Fisher Scientific, USA).
Carboxyfluorescein succinimidyl ester (CFSE) conjugation and
fluorescent microscopy
Discrete amplified scFv-phages (Bp-pre, Bp-R3-A or Bp-R3-ES) were diluted to 1 x 1011 TU/
ml and labelled with 120 μg of carboxyfluorescein succinimidyl ester (CFSE; 10 mg/ml in
DMSO) in a total volume of 1 ml PBS for 1 hr at RT in the dark, with agitation. Excess CFSE
was removed by overnight dialysis against PBS at 4°C. Microscopy was conducted using CFSE
labelled scFv-phages (Bp-pre, Bp-R3-A or Bp-R3-ES). Briefly, 10 ± 2 formaldehyde-fixed adult
worm pairs were reacted with 1 x 109 TU/ml phage particles diluted in PBS for 1 hr at RT in
the dark. Parasites were washed five times with 1.5 ml of PBS-T and an additional two times
with PBS. Parasites were mounted on slides using PBS with 10% glycerol (Merck-Millipore,
Germany). Images were taken using a Zeiss fluorescence microscope (Zeiss Group, Germany)
and a 2.5x objective with a consistent exposure time for each sample. Images were processed
using Zen software (Zeiss Group, Germany). At least 10 adult parasites were observed for each
represented image. Confocal microscopy was performed using a Nikon SMZ 25 stereomicro-
scope with a motorised stage with CFSE labelled Bp-R3-A phage and formaldehyde-fixed adult
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parasites. Two hundred images were captured at 10.8 μm steps with fixed exposure times and
an SHR Plan Apo 2x objective. The images shown were reconstructed and rendered using Ima-
geJ software [34].
Protein microarray screening and scanning
Amicroarray consisting of 232 schistosome specific proteins was prepared as described [35].
Briefly, array pads were hydrated with Whatman Blocking Buffer (WBB; Whatman, GE
Healthcare, UK). Phages (M13K07 helper-phage control, Bp-R3-A or Bp-R3-ES phages) were
pre-absorbed in WBB containing 10% (w/v) reconstituted E. coli lysate (EBB; Mc Lab, USA).
Binding of scFv-phage particles was detected by addition of anti-M13 pIII monoclonal anti-
body (diluted 1:1000 in WBB; New England Biolabs, USA), biotin-anti-mouse antibody
(diluted 1:1000 in WBB; Jackson Immunoresearch, USA), then streptavidin-conjugated Cy5
fluorophore (diluted 1:200 in WBB; Surelight P3, Columbia Biosciences, USA). Microarray
pads were washed 3 times with TBS-T, 3 times with TBS, then in ultrapure water and dried by
centrifugation at RT in a 50 ml Falcon tube (BD Biosciences, USA) for 5 min at 500 g.
Microarray slides were scanned using a confocal laser microarray scanner (Genepix 4300A,
Molecular Devices, USA). The signals were quantified with image analysis software (Genepix
Pro 7, Molecular Devices, USA) and the reported feature intensity was calculated by subtract-
ing the median local background signal from the feature signal.Data was analysed using a varia-
tion of the “group average” method [36, 37]. Signal intensity (S.I.) greater than the average of
the “No DNA” negative controls plus 2.5 standard deviations (S.D.) and no binding by
M13K07 helper-phage was used to determine positive recognition. Binding intensity was desig-
nated on a plus minus scale. Sequences of identified antigens were then analysed for develop-
mental expression based on previous work [38] and EST Profile Viewer (http://www.ncbi.nlm.
nih.gov).
Statistical analysis
Differences between scFv-phages or soluble scFv clones was determined using a one- or two-
way analysis of variance test (ANOVA) followed by a Tukey’s post-hoc test. Statistical results
were reported when significance was achieved at P< 0.05. Statistical analysis was performed
using GraphPad Prism, version 6.01 software.
Results
Generation and enrichment of a scFv-phage library from infected buffalo
portal-lymph nodes
The VH and VL antibody regions were amplified from buffalo portal lymph nodes 11–12 days
post infection with S. japonicum and cloned into a scFv-phage vector (S1A Fig). Sequencing of
assembled scFv fragments revealed framework similarities and distinct variation in the comple-
mentarity determining regions (CDR; S1B Fig). Transformation into XL-1 Blue E. coli cells
produced approximately 1.5 x 107 colonies. Panning against whole fixed adult worm pairs and
ES products resulted in relative enrichment levels of greater than 800 or 80 fold, respectively,
(S2 Fig). Libraries generated from this material are prefixed with Bp-R3.
Bp-R3 scFv-phage libraries bind to adult schistosomes and ES products
Bp-R3 phages were mixed with formaldehyde-fixed adult worm pairs and binding was assessed
by fluorescent staining (Fig 1). Following three rounds of panning against intact adult worms
CFSE labelled Bp-R3-A and Bp-R3-ES phage libraries displayed increased fluorescent binding
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Fig 1. Buffalo portal-round three selected (Bp-R3) single-chain Fv domain (scFv) phage recognise adult Schistosoma japonicum parasites and
extracts. Identical numbers of carboxyfluorescein succinimidyl ester (CFSE) conjugated non-scFv expressing M13K07 helper-phage (A1), Bp-pre (A2), Bp-
R3-A (A3) or Bp-R3-ES (A4) scFv-phage pools were incubated with formaldehyde-fixed adult worm pairs. Whole S. japonicum adult parasite images
captured with consistent exposure times are presented as dark field (A1, a-d) and FITC fluorescence images (A1, e-h). Three dimensional rendered image of
CFSE labelled Bp-R3-AES scFv-phages binding to adult S. japonicum (B1). A total of two hundred images were captured at 10.8 μm steps with consistent
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to adult worm pairs under constant exposure conditions compared with CFSE labelled phage
prior to selection (Bp-pre) and control M13K07 helper phage (Fig 1A 3–4 compared to 1–2).
To determine where on the adult schistosome the Bp-R3 phage bound we performed confocal
microscopy using CFSE labelled Bp-R3 phages and adult schistosomes (Fig 1B). It demon-
strated that binding to fixed parasites was primarily restricted to the surface, with no apparent
binding to internal structures (Fig 1B-2). Interestingly, although initially binding appeared to
be uniform (Fig 1A), confocal examination indicated there are regions on the surface of the
parasite where phage do not bind in sufficient numbers to obtain a positive fluoresce signal
(Fig 1B-1 arrows). To quantitate phage binding to schistosome ES products we coated an
ELISA plate with ES antigens and added different phage libraries, this showed that the enriched
Bp-R3-ES phage library displayed significantly greater binding to ES products than any other
phage library (Fig 1C). The Bp-R3-A library selected for adult binding also bound ES antigens
more strongly than control phage, indicating the ES and adult surface likely share cross-reac-
tive epitopes (Fig 1C).
Bp-R3 scFv-phage libraries recognise stage-specific antigens on protein
microarrays
Screening of a schistosome specific protein microarray with Bp-R3 phages (Adult or ES)
resulted in significant recognition of ten antigens. All ten of these antigens were recognised by
the Bp-R3-ES phages, however only three antigens were consistently recognised by both the
Bp-R3-A and Bp-R3-ES phages. These were a hypothetical protein (NCBI GenBank accession
number AY808393), a protein similar to the myosin heavy chain (SJCHGC09420;
AY8153690) and the previously defined Sjp40 protein (AY814158) (Table 1).
Other antigens recognised by the Bp-R3 phages included an additional four hypothetical
proteins (AY811797, AY814150, AY815838 and AY808749) and a further four known pro-
teins, including tropomyosin (AY809972), a calponin-like protein (AY813467), a putative
dynein light chain-1 protein (DLC1; AY915388) and a protein similar to myosin heavy chain
(AY815690). The tropomyosin antigen (SJCHGC02287) is a 25 kDa protein expressed in a
range of tissues at different developmental stages and is associated with muscle contraction
and cystoskeletal structure and function [39]. Although tropomysins are not specific to schisto-
somes, the SJCHGC02287 tropomyosin variant shares less than 50% homology with any other
organism outside the schistosome genus. The calponin-like antigen shares homology with a 38
kDa S. japonicum calponin, which has been previously investigated [40]. The DLC1 from S.
japonicum has previously been investigated as a potential target for vaccine or drug develop-
ment [41]. The function of the AY815838 hypothetical protein is currently unknown, but the
sequence has some homology to the S.mansoni surface antigens Sm13 (AAC25419.1; 30%)
and Sm25 (AAA29943; 34%). Interestingly, all of the schistosome specific antigens identified
using the array show increased binding with the Bp-R3-ES selected phage indicating that these
antigens may be excreted or secreted into the host vasculature. It should be noted that the pro-
teins observed in Table 1 were often identified in one life-stage by proteomic analysis, but had
expressed sequence tags (ESTs) in many life-stages or vice versa. This apparent inconsistency
may reflect the incompleteness of the proteomic datasets available for analysis or the fact that
mRNA levels do not necessarily correlate with protein expression.
exposure time. Arrows represent areas of minimal binding (B1). Cross sectional view of scFv-phage binding to adult schistosome showing binding is
restricted to the surface of the parasite, with no observable binding to internal structures (B2). Bp-R3 scFv-phages bind to S. japonicum excretory-secretory
(ES) protein extracts by ELISA (C). Data represent mean ± S.E.M. of the O.D.450nm for discrete scFv-phage pools binding to ES protein preparations (C).
Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc test, where ** P < 0.01, *** P < 0.001, **** P < 0.0001.
doi:10.1371/journal.pntd.0004280.g001
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Bp-R3-AES scFv-phage pools recognise adult schistosome protein
extracts
We pooled the Bp-R3-A and Bp-R3-ES to widen the pool of potential phage sequences selected
for adult and secreted schistosome epitopes and analysed the specificity of the pooled Bp-
R3-AES library to bind to different schistosome antigen preparations by ELISA (Fig 2). The
Bp-R3-AES phages showed significant levels of binding towards SWAP (p< 0.05) (Fig 2A)
indicating they recognised adult proteins. There was no observed binding of the Bp-R3-AES
pool to the SEA preparation (Fig 2B) and background binding by M13K07 helper-phage to any
antigen preparation was negligible (Fig 2A and 2B). Western blotting of Bp-R3-AES phages
was also performed against S. japonicum derived SWAP and SEA preparations (Fig 2C). The
Bp-R3-AES phages bound to a broad range of epitopes within the SWAP preparation, but as
observed using ELISA, did not recognise any epitopes within the SEA preparation (Fig 2C;
Lane 2). Although the lack of SEA reactivity was unexpected, for a diagnostic aimed to detect
an active adult infections, lack of SEA reactivity could be advantageous.
Isolated soluble scFv clones preferentially recognise SWAP antigens
The buffalo derived Bp-R3-AES phages were further panned against infected mouse sera to
eliminate scFv-phage sequences that bind epitopes within sera, and enrich for antigens that are
excreted into the serum during an experimental infection. This process generated a library des-
ignated Bp-R3-PIMS, which displayed similar binding to SWAP proteins when compared to
the Bp-R3-AES libraries as determined by ELISA (Fig 3A). Five soluble alkaline phosphatase
(AP) scFv fusion proteins were generated from the Bp-R3-PIMS library (Bp-scFv-1 to Bp-
scFv-5; S3 Fig).
Table 1. Schistosoma japonicum protein microarray antigen recognition by buffalo portal-round three selected (Bp-R3) single-chain antibody Fv
domain (scFv) phages.
Recognition by
R3-scFv-phage a
Life cycle stage
b
Protein name NCBI GenBank Accession
number
R3-scFv-
A
R3-scFv-
ES
EST Protein Schistosome
speciﬁc c
SJCHGC02287; Tropomyosin AY809972 - +++ A CSAEM No
Hypothetical protein containing DNA-binding
SAP domain
AY811797 - ++ A S Yes
Hypothetical protein AY808393 ++ ++++ A S Yes
Calponin-like AY813467 - +++ SA CSA No
Hypothetical protein AY814150 - ++ SA S Yes
Hypothetical protein AY815838 - + S CA Yes
Sjp40; similar to P40_SCHMA Major egg
antigen (P40)
AY814158 ++++ ++++ SAEM CSAEM No
SJCHGC05640; Putative dynein light chain-1 AY915388 - + SAE CSE No
Hypothetical protein AY808749 - + A - Yes
SJCHGC09420; similar to myosin heavy chain AY815690 +++ ++++ SA CSAEM No
a Recognition level score: the average signal intensity of binding which was greater than 2.5 standard deviations of controls. Very high (++++) >1000
signal intensity (SI), High (+++) 500–999 SI; Moderate (++) 100–499 SI; low (+) 0–99 SI; (-) not a signiﬁcant hit.
b Life stage with highest expression is based on previous work [38]: cercariae (C), schistosomula (S), adult (A), egg (E) or miracidium (M).
c Schistosome speciﬁc proteins are deﬁned as those with no orthologues protein in other species via proteomic analysis [38].
doi:10.1371/journal.pntd.0004280.t001
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Fig 2. Binding of buffalo portal-round three selected-adult and ES pooled (Bp-R3-AES) single-chain Fv domain (scFv) phage library to
Schistosoma japonicum protein extracts.Data represent mean ± S.E.M. of the O.D.450nm for Bp-R3-AES phage binding to soluble whole adult
preparations (SWAP) (A) and soluble egg antigens (SEA) (B). Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc test,
where * P < 0.05. Antigens from SWAP (Lane 1), and SEA (Lane 2) of S. japonicumwere probed with Bp-R3-AES phage (C). Molecular weights in
kilodaltons (kDa) are indicated on the left hand side. Regions of intense binding by Bp-R3 scFv phages to antigen preparations is indicated by arrows.
doi:10.1371/journal.pntd.0004280.g002
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Fig 3. Binding of buffalo portal-round three selected (Bp-R3) single-chain antibody Fv domain (scFv) phage panned against infectedmouse sera
and scFv-alkaline phosphatase (scFv-AP) fusion proteins to Schistosoma japonicum soluble whole adult preparation (SWAP) by ELISA.Data
represent mean ± S.E.M. of the O.D.450nm for Bp-R3-A and ES pooled phage libraries (Bp-R3-AES) and Bp-R3-post-infected-mouse-sera (Bp-R3-PIMS)
phage binding to S. japonicum SWAP (A), and scFv-AP proteins (Bp-scFv-1 to Bp-scFv-5) binding to SWAP (B and C) or SWAP spiked naive mouse sera
(D). Antibodies derived from an S. japonicum infected rabbit (infected antibodies) were used as a positive control (D#). Statistical significance was
determined by one- or two-way ANOVA followed by Tukey’s post-hoc test, where * P < 0.05, *** P < 0.001, **** P < 0.0001.
doi:10.1371/journal.pntd.0004280.g003
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All identified scFv-AP proteins (Bp-scFv-1 to Bp-scFv-5) showed significantly higher bind-
ing to SWAP relative to an ovalbumin protein binding control as examined by ELISA (Fig 3C).
An E. coli lysate control, containing no expressed scFv-AP protein, showed no reactivity
against SWAP protein extract (Fig 3B). Two of the scFv-AP clones (Bp-scFv-1 and Bp-scFv-2)
were also able to significantly and preferentially recognise SWAP proteins that had been spiked
into naïve mouse sera by ELISA (Fig 3D)
Sequencing of the scFv-AP clones (Fig 4) revealed high conservation of framework
sequences within both the VH and VL regions with significant variations only within the com-
plementarity determining (CDR) regions. As expected within antibody sequences, the major
region of diversity observed was within the CDR 3 of the heavy chain (CDRH3; Fig 4) with
amino acid sequence length ranging from 4–16 amino acids.
Discussion
There has been considerable success at reducing transmission and infection rates of S. japoni-
cum in the PR China [42], however, there is a need to ensure the parasite life cycle is completely
broken and that the national elimination program does not falter due to a significant number
of low-level infections not being detected [11]. In areas where schistosomiasis japonica remains
a problem there is a need to measure and target treatments as well as to educate communities
[43]. If a significant number of low-level infections go undetected, there is the risk that the
efforts already employed to control transmission will be in vain [11].
The Kato-Katz stool smear technique has been the backbone of intestinal schistosomiasis
diagnosis in epidemiological studies, and in the case of S. japonicum is the only approved mea-
sure for diagnosis of current infection [20, 44]. However, the technique is becoming less useful
in regions where control programs have resulted in light parasite infections [45, 46]. The vast
majority of diagnostic measures for schistosomiasis are underestimating parasite burdens [47,
48]. This is of particular concern for prevention strategies being employed in regions of PR
China where accurate diagnosis is crucial for the effective control and surveillance of the dis-
ease [49]. The most recent epidemiological surveys suggest that the prevalence of S. japonicum
infection in areas where transmission has not yet been controlled is 5.1% [49] and, as the coun-
try strives for elimination of schistosomiasis, the need for more reliable diagnostic tests to sur-
vey parasite prevalence is essential [50].
A number of diagnostic tests that detect the host antibody response to schistosome infection
have been developed and are being integrated into national control programs in endemic areas
of PR China. These include the circumoval precipitin test (COPT), the silver-enhanced colloi-
dal gold metalloimmunoassay, enzyme-linked immunosorbent assay (ELISA), indirect hemag-
glutination assay (IHA), dot immunogold filtration assay (DIGFA) and dipstick dye
immunoassay (DDIA), [44, 51–53]. These tests provide a more accurate measure of infection
than stool based parasitological tests with greater patient compliance as they are less invasive
[44]. The DDIA test is now commercially available as a test for S. japonicum in low endemic
regions [53]. However, it should be noted that due to the lack of strict approval guidelines in
PR China, many poor performing diagnostic tests are also being used [44]. A study by Cai and
colleagues further confirmed three of the antibody based diagnostic tests (IHA, ELISA and
DDIA) successfully identify schistosomiasis infected patients [49]; however none are able to
accurately distinguish between current or cured infection status and thus assessment of treat-
ment outcomes is difficult.
More recently a number of assays to detect circulating antigen have been described. Detec-
tion of two circulating diagnostic antigens, circulating cathode antigen (CCA) and circulating
anode antigen (CAA), have been developed into diagnostic tests for detection and diagnosis of
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schistosomiasis. A point-of-care (POC) CCA test is now commercially available and has
proven successful for detection of intestinal S.mansoni, and has been proposed as an alterna-
tive to the replicate Kato-Katz measurements [20, 54]. The POC-CCA test is effective in
endemic regions, yet its efficacy in areas of low intensity infections requires validation [14, 18,
55, 56]. Recent work by van Dam and colleagues demonstrated that a new technique to
enhance CAA detection in sera and urine was six fold more sensitive at diagnosing an active
schistosome infection when compared to Kato-Katz measurements [14]. The significant
advantage of a sensitive and reliable antigen based diagnostic for schistosome infection is the
ability to discriminate active infection. Yet, immunological tests are currently still expensive
and often require trained technicians for the administration and analysis, which increases cost
and demand for infrastructure [57]. Moreover, the ability of these tests to assess drug efficacy
and provide information regarding the impact of control interventions stills needs to be evalu-
ated [20].
Fig 4. Clustal Omega alignment of soluble single-chain antibody Fv domain-alkaline phosphatase (scFv-AP) antibody sequences. Complementarity
determining regions (CDR) regions of variable light (CDRL1-3) and variable heavy (CDRH1-3) chains are indicated in boxes. Respective VL and VH regions
show similarity within the framework regions and distinct differences within CDR regions, particularly within CDRH3. (*) indicates a fully conserved residue,
(:) a strongly similar and (.) a weakly similar residue.
doi:10.1371/journal.pntd.0004280.g004
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The zoonotic nature of S. japonicummakes animals, particular water buffaloes, significant
infection reservoirs. Water buffalo have been thought to contribute to 75% of human infections
[13, 58] and prevalence of infection within buffalo populations has been reported to be as high
as 10% [59]. It is likely that control within humans living in close proximity to water buffalo
will require accurate diagnosis of residual infection within these buffalo populations. This will
likely require a low cost easy to administer test that accurately determines infection status.
The novel phage display approach used in this study incorporates the natural reservoir host
of S. japonicum to generate mature antibody fragments that bind to adult schistosomes and ES
products. The matured buffalo antibody fragments should show little cross-reactivity with buf-
falo proteins and may help form the basis of a reagent to diagnose infection in buffalo. Further-
more, we have recently shown that buffalo CDRH3 regions selected for binding to
schistosomules using the antibody phage display system are longer than those from non-
selected libraries, suggesting that long CDRH3 regions may be important in host parasite anti-
gen recognition [22]. Recent studies have shown that long CDRH3 regions are pivotal in the
successful defence against dangerous viral infections such as HIV [60] and although the func-
tional mechanisms for ultra-long CDRH3 regions in cattle has yet to be elucidated [61] they
may offer advantages for diagnostic development. Although we did not observe ultra-long
CDRH3 regions in the five soluble scFv-AP clones characterised they are only a very small sub-
set of the total number of clones generated.
Previous studies have utilised phage display technology to investigate the maturation of dis-
played antibody or peptide fragments toward specific S. japonicummolecules [62–64]. These
studies primarily involved the identification of peptide binders through the use of commercial
peptide-phage display libraries. The present study used the immunological status of infected
host animals to select from a B-cell repertoire primed to produce variable regions that recog-
nise immune exposed epitopes present in the host at the time of sacrifice, i.e. when adult para-
sites reach the hepatoportal circulation. Previous studies by McWilliam et al., have illustrated
the ability of selected activated lymph node antibodies to discriminate against particular stages
of S. japonicum [21, 28]. We have expanded on this principle by producing scFv-phage libraries
from activated lymph nodes to allow molecular characterisation and easier production of the
binding moity, which can be difficult to isolate from lymph node antibody preparations.
Following selection against defined antigen pools, the binding profile of Bp-R3 phages
against SWAP antigens still displayed reactivity to a broad range of antigens, with significant
recognition towards three distinct regions, suggesting affinity maturation of Bp-R3 phages
towards specific antigens within SWAP. Examination of Bp-R3 phages by ELISA revealed that
Bp-R3 phages selected against adult worms or ES preparations were positively and significantly
selected towards the antigenic preparations for which they were panned. This observation indi-
cates the maturation of different antibody paratopes within the two scFv-phage libraries. How-
ever, it should be noted that microscopy and ELISA observations did indicate cross-reactivity of
the differentially selected Bp-R3-A and Bp-R3-ES phage libraries. When analysed on a protein
microarray, specific for schistosome proteins, the Bp-R3 phage libraries bound a number of
known and hypothetical proteins. Importantly, the library enriched on ES derived material dis-
played stronger binding to all detected proteins, suggesting that these epitopes may be secreted
by the parasite and are presented within the blood of infected individuals. Interestingly, three of
the proteins recognised (AY814158, AY815690 andAY915388) have previously been observed
using an scFv-phage library selected against the larval stages of S. japonicum [22]. Recent work
by Silas and colleagues has identified splice variants of tropomyosin (AY809972) within S.man-
soni that may be associated with natural immunity within the definitive host [39]. Their work
identified high IgE and IgG4 antibody titres following exposure to S.mansoni tropomyosin vari-
ants indicating tropomyosin is available to the immune system during a natural infection.
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This present work also identified and characterised five unique soluble scFv-AP clones
selected from the Bp-R3-PIMS phage library, which had been panned against serum obtained
from S. japonicum infected mice. This blood panning, in particular the initial selection against
naïve sera, was performed to both eliminate scFvs that preferentially bind to blood proteins
and enrich for scFv-phages that bind schistosome antigens present in blood following infec-
tion. All of the isolated soluble scFv-AP clones (Bp-scFv-1 to Bp-scFv-5) significantly bound to
SWAP proteins. Importantly a lysate control, containing no expressed scFv, did not recognise
SWAP proteins and no purified scFv-AP clone specifically recognised ovalbumin, a non-
related protein binding control. Only two of the five scFv-AP clones were able to significantly
detect SWAP above the level of background mouse blood proteins in an ELISA using naïve
mouse sera spiked with SWAP antigens. This suggests that the scFv-phage technique can iso-
late antibody fragments that recognise schistosome antigens in blood. However, further valida-
tion and isolation of these scFv antibody fragments is required to ensure they exclusively
recognise schistosome antigens in naturally infected animals.
The development of a range of approaches to deliver accurate point of care, rapid schisto-
some diagnosis will be critical in the fight to eradicate schistosomiasis japonica in areas of low
but continuing transmission in PR China. Here we describe the use of the natural buffalo host
to develop and identify recombinant scFv fragments that bind adult stage and ES antigens
from S. japonicum. The isolated soluble scFv clones require further development, purification
and testing within a true schistosomiasis japonica infection setting, but once completed could
be valuable reagents in the construction of a cost effective point-of-care diagnostic test.
Supporting Information
S1 Fig. Cloning procedure and amplification of single-chain antibody Fv domain (scFv)
inserts. Total RNA from the portal-LN collected 11–12 days post Schistosoma japonicum cer-
carial infection was reverse transcribed to cDNA. Variable heavy (VH) and variable light (VL)
genes were amplified (A). Full length scFv fragments were assembled by splice overlap PCR
and the full length scFv construct was amplified using scFv specific primers (A#). Molecular
weights in base-pairs (bp) are indicated. Full length scFv fragments were inserted into pAK100
vector via SfiI cloning. Selected phagemid were sequenced and aligned to cattle variable regions
(B). Shaded regions represent complementarity determining regions (CDR) for VH and VL
genes; () indicates a fully conserved residue, (:) a strongly similar and (.) a weakly similar resi-
due.
(TIF)
S2 Fig. Relative enrichment of functional single-chain Fv domain (scFv) phage particles.
Binding to adult Schistosoma japonicum worms and excretory secretory (ES) products was
determined using the relationship between the output titre from scFv-phage eluted from adult
S. japonicum worms or ES products at each round and control reactions containing no parasite
material.
(TIF)
S3 Fig. Expression of soluble single-chain Fv domain (scFv) alkaline phosphatase (AP)
fusion proteins. Soluble scFv-AP clones were expressed and probed with anti-AP-HRP and
positive expression is indicated. A soluble scFv-His tag control protein was expressed and
probed with anti-His-HRP and is also indicated. Molecular weights in kilodaltons (kDa) are
indicated on the left hand side.
(TIF)
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